Loading...
  • clinical
  • All available in vitro and clinical data on cladribine was undertaken. (diva-portal.org)
  • Ortho-Clinical, a subsidiary of J&J, filed an NDA for cladribine for MS in 1997 but withdrew it in the late 1990s after discussion with the FDA proved that more clinical data would be needed. (wikipedia.org)
  • To determine if MRD levels and tumor markers (soluble CD25 and CD22) after cladribine and/or rituximab correlate with response and clinical endpoints. (clinicaltrials.gov)
  • treatment
  • however, severe neurological toxicity has been reported rarely following treatment with standard cladribine dosing regimens. (drugs.com)
  • Before you begin treatment with cladribine, you and your doctor should talk about the good cladribine will do as well as the risks of using it. (drugs.com)
  • It is suggested that it is easy to use and that oral Cladribine, will have a major impact on the treatment of MS. (healingwell.com)
  • No treatment has achieved a high complete remission (CR) rate even in small series, and of 39 reported cases from six studies, overall response rate after cladribine was 44% with 8% CRs. (nih.gov)
  • Cladribine treatment was well tolerated without any side effects. (thisisms.com)
  • cancer
  • Cladribine produces its anti-cancer effects by inhibiting the ability of a cell to produce DNA or repair DNA. (unm.edu)
  • Cladribine fights cancer by preventing the growth of cancer cells, which eventually results in their destruction. (pharmasave.com)
  • As well as interfering with the genetic material DNA of cancer cells, cladribine can interfere with some of your normal cells. (pharmasave.com)
  • Last
  • so, this only looks at one piece of a complex puzzle but since my last serum d3 test came back at 166 nmol/l, i'm not in any rush to try cladribine just on the off-chance it may help with a possibly non-existent elevated neurofilament light chain problem. (thisisms.com)
  • medicines
  • Using cladribine with any of the following medicines is not recommended. (drugs.com)
  • Using cladribine with any of the following medicines is usually not recommended, but may be required in some cases. (drugs.com)
  • Cladribine is currently being appraised by the Scottish Medicines Consortium (SMC) and we are contributing to the appraisal. (mstrust.org.uk)
  • side
  • Although there is no specific information comparing use of cladribine in the elderly with use in other age groups, it is not expected to cause different side effects or problems in older people than it does in younger adults. (drugs.com)
  • You will be checked regularly by your doctor while you are taking Cladribine, to monitor side effects and check your response to therapy. (shift.ms)
  • study
  • In a phase III study, cladribine reduced relapses by 58% compared to placebo and also reduced the risk of disability progression. (mstrust.org.uk)
  • course
  • Year one - In the first course, cladribine pills are taken for four or five days consecutively at the beginning of the first month and then four or five days consecutively at the beginning of the second month. (mstrust.org.uk)
  • blood
  • However, cladribine has been reported to be tested in children with certain types of cancers of the blood. (drugs.com)
  • Cladribine can lower blood cells that help your body fight infections and help your blood to clot. (rxlist.com)